Loading clinical trials...
Loading clinical trials...
Arsenic Trioxide Alone or With ATRA (Vesanoid) for Resistant Hematologic Malignancy
Conditions
Interventions
arsenic trioxide
tretinoin
Locations
1
United States
Washington University Barnard Cancer Center
St Louis, Missouri, United States
Start Date
June 1, 1999
Primary Completion Date
November 1, 2000
Completion Date
February 1, 2002
Last Updated
February 6, 2013
NCT06337318
NCT06311227
NCT06285890
NCT06263491
NCT05139017
NCT07388563
Lead Sponsor
Washington University School of Medicine
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions